Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia.
Chandesris
M-O
MO
Gayet
S
S
Schleinitz
N
N
Doudier
B
B
Harlé
J-Robert
JR
Kaplanski
G
G
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D017211:Treatment Failure; D014657:Vasculitis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D000069285:Infliximab